KYMERA THERAPEUTICS Trademark

Trademark Overview

On Thursday, November 22, 2018, a trademark application was filed for KYMERA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the KYMERA THERAPEUTICS trademark a serial number of 88203328. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 12, 2024. This trademark is owned by Kymera Therapeutics, Inc.. The KYMERA THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

House mark for pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncology and other related diseases; House mark for pharmaceutical and medical therapeutics for the treatment of oncology, autoimmune, immune-oncology and other related diseases; House mark for diagnostic reagents for the treatment of oncology, autoimmune, immune-oncology and other related diseases
kymera therapeutics

General Information

Serial Number88203328
Word MarkKYMERA THERAPEUTICS
Filing DateThursday, November 22, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 8, 2019

Trademark Statements

Goods and ServicesHouse mark for pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncology and other related diseases; House mark for pharmaceutical and medical therapeutics for the treatment of oncology, autoimmune, immune-oncology and other related diseases; House mark for diagnostic reagents for the treatment of oncology, autoimmune, immune-oncology and other related diseases
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 12, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKymera Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472
Party NameKymera Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, February 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 12, 2024ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 1, 2023CORRECTED NOA E-MAILED
Tuesday, August 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 31, 2023SOU EXTENSION 5 GRANTED
Monday, July 10, 2023SOU EXTENSION 5 FILED
Monday, July 31, 2023DIVISIONAL PROCESSING COMPLETE
Friday, July 7, 2023DIVISIONAL REQUEST RECEIVED
Monday, July 31, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 10, 2023TEAS REQUEST TO DIVIDE RECEIVED
Monday, July 10, 2023SOU TEAS EXTENSION RECEIVED
Friday, January 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 11, 2023SOU EXTENSION 4 GRANTED
Wednesday, January 11, 2023SOU EXTENSION 4 FILED
Wednesday, January 11, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 12, 2022SOU EXTENSION 3 GRANTED
Tuesday, July 12, 2022SOU EXTENSION 3 FILED
Tuesday, July 12, 2022SOU TEAS EXTENSION RECEIVED
Thursday, January 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 11, 2022SOU EXTENSION 2 GRANTED
Tuesday, January 11, 2022SOU EXTENSION 2 FILED
Tuesday, January 11, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, July 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 12, 2021SOU EXTENSION 1 GRANTED
Monday, July 12, 2021SOU EXTENSION 1 FILED
Monday, July 12, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, January 12, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, December 3, 2020TTAB RELEASE CASE TO TRADEMARKS
Thursday, December 3, 2020OPPOSITION TERMINATED NO. 999999
Monday, November 2, 2020OPPOSITION DISMISSED NO. 999999
Thursday, November 14, 2019OPPOSITION INSTITUTED NO. 999999
Thursday, November 7, 2019OPPOSITION PAPERS RECEIVED AT TTAB
Tuesday, October 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2019PUBLISHED FOR OPPOSITION
Wednesday, September 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 5, 2019ASSIGNED TO LIE
Tuesday, September 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, August 24, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 23, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 23, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 26, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 26, 2019NON-FINAL ACTION E-MAILED
Tuesday, February 26, 2019NON-FINAL ACTION WRITTEN
Monday, February 25, 2019ASSIGNED TO EXAMINER
Wednesday, December 12, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 26, 2018NEW APPLICATION ENTERED

Related Keywords

therapeutics kymera oncology house immune related diseases other autoimmune mark treatment pharmaceutical